Wall Street analyst estimates for Covista Inc. (CVSA): consensus price target, buy/hold/sell recommendations and forecasts for revenue, EPS and EBITDA for the upcoming fiscal years.
Adtalem Global Education, Inc. is an enterprise dedicated to providing higher education. The company organizes its operations into three primary divisions: Chamberlain, Walden, and Medical and Veterinary. The Chamberlain segment delivers various degree and non-degree offerings within the nursing and broader health professions higher education sector.
Analyst Consensus
| Strong Buy | 0 |
| Buy | 2 |
| Hold | 1 |
| Sell | 0 |
| Strong Sell | 0 |
| Total analysts | 3 |
| Avg rating (1-5) | 0.67 |
Recent Earnings Surprises
| Date | EPS Actual | EPS Est. | vs Est. |
|---|---|---|---|
| 2026-10-29 | $1.83 | ||
| 2026-08-06 | $2.09 | $1.89 | +10.6% |
| 2026-05-07 | $1.98 | $1.73 | +14.5% |
| 2026-01-28 | $2.43 | $2.19 | +11.0% |
| 2025-10-30 | $1.75 | $1.58 | +10.8% |
| 2025-08-07 | $1.66 | $1.53 | +8.5% |
| 2025-05-08 | $1.92 | $1.65 | +16.4% |
| 2025-01-30 | $1.81 | $1.37 | +32.1% |
Valuation Ratios
| P/E Ratio | 16.61 |
| Price / Book | 2.95 |
| EV / EBITDA | 10.41 |
| Dividend Yield | 0.00% |
Income Statement (10y)
| Year | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $1.21B | $1.24B | $1.01B | $1.05B | $906.9M | $1.38B | $1.45B | $1.58B | $1.79B | $1.95B |
| Cost of Revenue | $638.2M | $624.9M | $468.9M | $484.2M | $446.9M | $729.9M | $676.7M | $698.5M | $771.4M | $833.7M |
| Gross Profit | $569.7M | $610.9M | $544.9M | $567.8M | $460.0M | $651.9M | $774.1M | $886.1M | $1.02B | $1.12B |
| Research & Development | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Selling, General & Admin | $369.0M | $327.7M | $359.3M | $280.3M | $292.5M | $566.5M | $576.0M | $614.5M | $671.1M | $730.7M |
| Operating Expenses | $434.2M | $380.4M | $362.2M | $401.7M | $303.5M | $496.4M | $547.8M | $669.0M | $675.3M | $730.7M |
| Operating Income | $135.5M | $230.5M | $182.7M | $166.1M | $156.5M | $155.6M | $226.3M | $217.1M | $341.5M | $389.7M |
| EBITDA | $257.6M | $283.3M | $223.4M | $265.5M | $210.8M | $264.4M | $326.3M | $347.0M | $427.3M | $467.3M |
| Interest Expense | $9.1M | $14.6M | $19.9M | $9.1M | $42.8M | $98.9M | $63.2M | $63.7M | $52.3M | $39.2M |
| Pre-tax Income | $130.6M | $198.5M | $139.7M | $237.2M | $83.4M | -$51.5M | $112.0M | $163.9M | $298.5M | $345.1M |
| Income Tax | $9.6M | $84.1M | $32.9M | -$6.4M | $13.1M | -$15.5M | $10.3M | $26.2M | $65.8M | $77.7M |
| Net Income | $122.3M | $33.8M | $128.8M | $202.2M | $76.9M | -$162.5M | $96.9M | $136.8M | $232.7M | $251.6M |
| EPS | $1.87 | $0.55 | $2.20 | $3.77 | $1.50 | $-3.36 | $2.27 | $3.49 | $6.27 | $7.18 |
| EPS (Diluted) | $1.87 | $1.10 | $2.17 | $3.74 | $1.49 | $-3.36 | $2.23 | $3.42 | $6.07 | $7.04 |
| Shares Outstanding (Diluted) | $64.0M | $62.3M | $59.3M | $54.1M | $51.6M | $48.4M | $45.6M | $40.3M | $38.3M | $35.7M |
Price
| Price | $125.39 |
| Market Cap | $4.3B |
| Exchange | NYSE |
| Country | US |
Explore sector: Consumer Defensive · Education & Training Services
More sections of CVSA: Overview · Financials · Valuation · Statistics · Technical · Ownership · News · Events
Discover more: Weekly Radar: the S&P 500 through the Buffett and Lynch methods · Investment Academy — learn to analyze stocks